SCHEMBL9190686

SCHEMBL9190686

CCCC[Si](CCCC)(CSc1cc(CCC)c(O)c(CCC)c1)CSc1cc(CCC)c(O)c(CCC)c1

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.33
DHFR P00374 1/20 0.32
PTGS2 P35354 3/20 0.32
AR P10275 1/20 0.30
TYR P14679 1/20 0.30
HMGCR P04035 1/20 0.30
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9188546 0.94 TYR (0.37) ALOX5PTGS2ARTYREGFR
SCHEMBL9190294 0.89 GABRA1 (0.33) DHFRAR
SCHEMBL9190227 0.85 DHFR (0.34) ALOX5DHFRHMGCR
SCHEMBL9192796 0.84 GABRA1 (0.38)
SCHEMBL9193207 0.83 DHFR (0.35) ALOX5DHFRHMGCR
SCHEMBL9193484 0.83 TYR (0.38) ALOX5PTGS2TYREGFR
SCHEMBL9194772 0.81 AR (0.38) PTGS2AR
SCHEMBL9195092 0.81 TYR (0.39) ALOX5PTGS2TYREGFR
SCHEMBL8573280 0.80 DHFR (0.35) ALOX5DHFRHMGCREGFR
SCHEMBL8579130 0.78 EGFR (0.40) ALOX5PTGS2TYREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0464844-B1 Novel bis (4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMA (US) 1995-12-27 EP disclosed
US-5304668-A Bis-[4-(2,6-di-alkyl)phenolisilane derivatives as antiatherosclerotic agents MERRELL DOW PHARMACEUTICALS (US) 1994-04-19 US disclosed
US-5281738-A Anticholesterol agents MERRELL DOW PHARMACEUTICALS INC. (US) 1994-01-25 US disclosed
EP-0464844-A1 Novel bis (4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMACEUTICALS INC. (US) 1992-01-08 EP disclosed